Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Ascendis Pharma A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Ascendis Pharma A/S, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Ascendis Pharma A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Ascendis Pharma A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Ascendis Pharma A/S, Medical Devices Deals, 2012 to YTD 2018 10
Ascendis Pharma A/S, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Ascendis Pharma A/S, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Ascendis Pharma Raises USD60 Million in Series D Venture Financing 12
Partnerships 14
Ascendis Pharma Enters Into Collaboration Agreement with Genentech 14
Equity Offering 15
Ascendis Pharma Raises USD258.7 Million in Public Offering of American Depositary Shares 15
Ascendis Pharma Prices Public Offering of American Depositary Shares for USD135 Million 17
Ascendis Pharma Raises USD120 Million in Public Offering of ADS 19
Ascendis Pharma Raises USD124 Million in IPO 21
Ascendis Pharma A/S – Key Competitors 23
Ascendis Pharma A/S – Key Employees 24
Ascendis Pharma A/S – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Financial Announcements 26
Aug 29, 2018: Ascendis pharma announces second quarter 2018 financial results 26
May 30, 2018: Ascendis Pharma Announces First Quarter 2018 Financial Results 27
Mar 28, 2018: Ascendis Pharma Announces Full Year 2017 Financial Results 28
Nov 16, 2017: Ascendis Pharma Reports Third Quarter 2017 Financial Results 29
Aug 18, 2017: Ascendis Pharma Reports Second Quarter 2017 Financial Results 30
May 23, 2017: Ascendis Pharma Reports First Quarter 2017 Financial Results 31
Mar 22, 2017: Ascendis Pharma Reports Full Year 2016 Financial Results 32
Corporate Communications 33
Apr 02, 2018: Ascendis Pharma Appoints Thomas A. Larson as Chief Commercial Officer 33
Product News 34
09/05/2017: Ascendis Pharma Announces Presentations on TransCon CNP at Upcoming Medical Conferences 34
09/05/2017: Ascendis Pharma Announces Presentations on TransCon PTH at Upcoming Medical Conferences 35
03/19/2018: Ascendis Pharma Announces Poster on TransCon Growth Hormone at ENDO 2018 36
02/28/2017: Ascendis Pharma Announces Data on TransCon CNP at ENDO 2017 37
02/28/2017: Ascendis Pharma Announces Data on TransCon PTH at ENDO 2017 38
Clinical Trials 39
May 08, 2018: Ascendis Pharma Announces Dosing of First Subjects in Phase 1 Trial of TransCon CNP 39
Jan 08, 2018: Ascendis Pharma Provides Update on TransCon CNP 40
Jan 08, 2018: Ascendis Pharma Provides Update on TransCon Growth Hormone 41
Jan 03, 2018: Ascendis Pharma Announces Completion of Target Enrollment in Phase 3 Trial of TransCon Growth Hormone for Pediatric Growth Hormone Deficiency 42
Sep 26, 2017: Ascendis Pharma Announces Dosing of Subjects in Phase 1 Trial of TransCon PTH 43
Apr 03, 2017: Ascendis Pharma Presents Data on TransCon CNP at ENDO 2017 44
Apr 03, 2017: Ascendis Pharma Presents Data on TransCon PTH at ENDO 2017 45
Apr 03, 2017: Ascendis Pharma Showcases New Data on Rare Disease Product Pipeline at ENDO 2017 46
Feb 28, 2017: Ascendis Pharma Announces Data on TransCon Growth Hormone at ENDO 2017 47
Feb 16, 2017: Ascendis Pharma Announces Publication of Comprehensive Results from Randomized, Active-Controlled Phase 2 Trial of Once-Weekly TransCon Growth Hormone in Pediatric Patients 48
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49
Ascendis Pharma A/S, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Ascendis Pharma A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Ascendis Pharma A/S, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Ascendis Pharma A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Ascendis Pharma A/S, Deals By Therapy Area, 2012 to YTD 2018 9
Ascendis Pharma A/S, Medical Devices Deals, 2012 to YTD 2018 10
Ascendis Pharma A/S, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Ascendis Pharma Raises USD60 Million in Series D Venture Financing 12
Ascendis Pharma Enters Into Collaboration Agreement with Genentech 14
Ascendis Pharma Raises USD258.7 Million in Public Offering of American Depositary Shares 15
Ascendis Pharma Prices Public Offering of American Depositary Shares for USD135 Million 17
Ascendis Pharma Raises USD120 Million in Public Offering of ADS 19
Ascendis Pharma Raises USD124 Million in IPO 21
Ascendis Pharma A/S, Key Competitors 23
Ascendis Pharma A/S, Key Employees 24
Ascendis Pharma A/S, Subsidiaries 25
List of Figures
Ascendis Pharma A/S, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Ascendis Pharma A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Ascendis Pharma A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Ascendis Pharma A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Ascendis Pharma A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Ascendis Pharma A/S, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Ascendis Pharma A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Ascendis Pharma A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Ascendis Pharma A/S, Medical Devices Deals, 2012 to YTD 2018 10